Jefferies Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Jefferies Group’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-46,500	Closed	-$2.91M	–	1924
2022 Q1	$2.91M	Buy	+46,500	New	+$2.51M	0.02%	559

Other funds holding AXNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jefferies Group's AXNX Position: Q2 2022 in Review

Jefferies Group sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2022, closing a stake of 4,131 shares — an estimated $259K sold.

Jefferies Group first reported a position in AXNX in Q1 2020 and held it in 3 quarters. The position peaked at $259K in Q1 2022. 196 funds tracked by Wall St. Rank hold AXNX as of Q2 2022.

Jefferies Group reported no remaining Axonics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Jefferies Group sold 4,131 Axonics, Inc. Common Stock shares in Q2 2022, an estimated $259K.
Jefferies Group first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
Jefferies Group's Axonics, Inc. Common Stock position peaked at $259K in Q1 2022.
196 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.